Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPension (IS)Preferred Shares IssuedProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Bruker (BRKR) Short-Term Debt repayments (2017 - 2025)

Bruker filings provide 9 years of Short-Term Debt repayments readings, the most recent being -$15.0 million for Q4 2025.

  • On a quarterly basis, Short-Term Debt repayments fell 106.69% to -$15.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $778.8 million, a 35.78% decrease, with the full-year FY2025 number at $778.8 million, down 35.78% from a year prior.
  • Short-Term Debt repayments hit -$15.0 million in Q4 2025 for Bruker, down from $574.7 million in the prior quarter.
  • In the past five years, Short-Term Debt repayments ranged from a high of $839.6 million in Q2 2024 to a low of -$15.0 million in Q4 2025.
  • Median Short-Term Debt repayments over the past 4 years was $1.4 million (2022), compared with a mean of $124.5 million.
  • Biggest five-year swings in Short-Term Debt repayments: plummeted 428.57% in 2023 and later surged 33480.0% in 2025.
  • Bruker's Short-Term Debt repayments stood at $2.3 million in 2022, then skyrocketed by 391.3% to $11.3 million in 2023, then skyrocketed by 1883.19% to $224.1 million in 2024, then tumbled by 106.69% to -$15.0 million in 2025.
  • The last three reported values for Short-Term Debt repayments were -$15.0 million (Q4 2025), $574.7 million (Q3 2025), and $51.2 million (Q2 2025) per Business Quant data.